Home / Recalls / New England Compounding Center / D-109-2013

D-109-2013 Class I Terminated

Recalled by New England Compounding Center — Framingham, MA

Recall Details

Product Type
Drugs
Report Date
January 9, 2013
Initiation Date
September 26, 2012
Termination Date
October 7, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9062 vials

Product Description

Methylprednisolone Acetate (PF) 40 mg/ml Injection, supplied in 1 mL, 2 mL and 5 mL vials, manufactured by New England Compounding Center, Framingham, MA

Reason for Recall

Non-Sterility

Distribution Pattern

Nationwide

Code Information

All lot codes

Other recalls by New England Compounding Center

  • D-053-2013 Class II — All Non Sterile Products manufactured by NECC (New England Compounding Center), (October 6, 2012)
  • D-052-2013 Class II — All Sterile Products manufactured by NECC (New England Compounding Center), Fram (October 6, 2012)
  • D-112-2013 Class II — Betamethasone Repository 6 mg/mL PF Injection and Betamethasone Repository 6 mg/ (September 26, 2012)
  • D-120-2013 Class II — Lidocaine/Dextrose 5%/7.5% PF, manufactured by New England Compounding Center, F (September 26, 2012)
  • D-110-2013 Class I — Methylprednisolone Acetate 40 mg/mL Injection, Preserved, supplied in 5 mL and (September 26, 2012)
  • D-123-2013 Class II — Saline 10% and 3%, in 5 mL and 10 mL vials, manufactured by New England Compound (September 26, 2012)
  • D-118-2013 Class II — Hyaluronidase 150 u/ml PF, 1 mL, 5 mL, and 10 mL vials, manufactured by New Engl (September 26, 2012)
  • D-117-2013 Class II — Glycerin 100% PF, 1mL, 2 mL, and 5 mL vials, manufactured by New England Compoun (September 26, 2012)
  • D-116-2013 Class II — Dexamethasone Sodium Phosphate 4 mg/mL vials PF, 6 mg/mL PF vials, and 8 mg/mL P (September 26, 2012)
  • D-113-2013 Class II — Betamethasone Sodium Phosphate 6 mg/mL P Injection, Betamethasone Sodium Phosph (September 26, 2012)